Background : Cognitive impairment, particularly in the elderly, affects millions of people globally. While many Omega-3 fatty acid (FA) formulations are available in Canada, their benefits for brain health/cognitive function are not well-defined. Objective: To identify the clinical efficacy of Omega-3 FA formulations in improving cognitive function. Methods: We performed PubMed searches for clinical efficacy evidence from randomized controlled trials on Omega-3 FAs and brain/mental/cognitive health. The clinical efficacy of each study was categorized by a 5-point scale: 0 = no effect, 1 = marginal, 2 = mild, 3 = moderate, 4 = prominent (p < 0.05), 5 = significant improvement (p < 0.001). We identified Omega-3 products that are available for cognitive health on the Canadian Market. Available Omega-3 FA product labels from local pharmacies and online stores were researched and reviewed. Results: No studies reported negative cognitive effects in patients. Supplements with Omega-3 showed clinical benefits in 3 categories of patients: mild cognitive impairment (MCI), Alzheimer’s disease (AD), and dementia, with a mean of “moderate effect” for all groups. Omega-3 formulations with a total dose > 1000 mg/day showed higher efficacy in all groups. Efficacy response to Omega-3 supplements correlated with total dose, and to a lesser degree with docosahexaenoic acid (DHA) dose. Omega-3 studies of DHA:EPA (eicosapentaenoic acid) ratios 3:1 and 4:1 showed the highest efficacy versus no effect. Conclusions: Omega-3 formulations with a total daily dose of ≥1000 mg and DHA:EPA ratio of 3:1 and higher are most effective compared to other formulations in improving cognitive function in patients with MCI, AD, and dementia.
World Health Organization (2022) World Mental Health Report. Transforming Mental Health for All. https://www.who.int/publications/i/item/9789240049338
Hall, J.H. and Hardwood, J.L. (2017) Brain Lipids in Health and Disease. In: Akoh, C.C., Ed., Food Lipids : Chemistry , Nutrition and Biotechnology , CRC Press, 747-764.
Sambra, V., Echeverria, F., Valenzuela, A., Chouinard-Watkins, R. and Valenzuela, R. (2021) Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients Throughout the Life Cycle. Nutrients , 13, Article 986. https://doi.org/10.3390/nu13030986
Bradbury, J. (2011) Docosahexaenoic Acid (DHA): An Ancient Nutrient for the Modern Human Brain. Nutrients , 3, 529-554. https://doi.org/10.3390/nu3050529
US National Institutes of Health (2024) ω -3 Fatty Acids. Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
Lacombe, R.J.S., Chouinard-Watkins, R. and Bazinet, R.P. (2018) Brain Docosahexaenoic Acid Uptake and Metabolism. Molecular Aspects of Medicine , 64, 109-134. https://doi.org/10.1016/j.mam.2017.12.004
Kuratko, C.N. and Salem, N. (2013) Docosahexaenoic Acid from Algal Oil. European Journal of Lipid Science and Technology , 115, 965-976. https://doi.org/10.1002/ejlt.201300060
Kotchetkov, A. and Kamel, M. (2025) ω -3 Fatty Acids and Mental Health: Assessment of Pharmacists’ Knowledge and Educational Needs. Canadian Journal of Educational and Social Studies , 5, 102-120.
Zhang, Y., Brown, R.E., Zhang, P., Zhao, Y., Ju, X. and Song, C. (2018) DHA, EPA and Their Combination at Various Ratios Differently Modulated A β 25-35 -Induced Neurotoxicity in SH-SY5Y Cells. Prostaglandins , Leukotrienes and Essential Fatty Acids , 136, 85-94. https://doi.org/10.1016/j.plefa.2017.07.003
Phillips, M., Childs, C., Calder, P. and Rogers, P. (2015) No Effect of ω -3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer’s Disease: A Randomised Controlled Trial. International Journal of Molecular Sciences , 16, 24600-24613. https://doi.org/10.3390/ijms161024600
Faxén Irving, G., Freund-Levi, Y., Eriksdotter-Jönhagen, M., Basun, H., Brismar, K., Hjorth, E., et al. (2008) ω -3 Fatty Acid Supplementation Effects on Weight and Appetite in Patients with Alzheimer’s Disease: The ω -3 Alzheimer’s Disease Study. Journal of the American Geriatrics Society , 57, 11-17. https://doi.org/10.1111/j.1532-5415.2008.02055.x
Freund-Levi, Y., Basun, H., Cederholm, T., Faxén-Irving, G., Garlind, A., Grut, M., et al. (2007) ω -3 Supplementation in Mild to Moderate Alzheimer’s Disease: Effects on Neuropsychiatric Symptoms. International Journal of Geriatric Psychiatry , 23, 161-169. https://doi.org/10.1002/gps.1857
Hooper, C., de Souto Barreto, P., Coley, N., Cantet, C., Cesari, M., Andrieu, S., et al. (2017) Cognitive Changes with ω -3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low ω -3 Index. The Journal of Nutrition , Health and Aging , 21, 988-993. https://doi.org/10.1007/s12603-017-0957-5
Boston, P.F., Bennett, A., Horrobin, D.F. and Bennett, C.N. (2004) Ethyl-EPA in Alzheimer’s Disease—A Pilot Study. Prostaglandins , Leukotrienes and Essential Fatty Acids ( PLEFA ), 71, 341-346. https://doi.org/10.1016/j.plefa.2004.07.001
Yurko‐Mauro, K., McCarthy, D., Rom, D., Nelson, E.B., Ryan, A.S., Blackwell, A., et al. (2010) Beneficial Effects of Docosahexaenoic Acid on Cognition in Age-Related Cognitive Decline. Alzheimer ’ s & Dementia , 6, 456-464. https://doi.org/10.1016/j.jalz.2010.01.013
Quinn, J.F., Raman, R., Thomas, R.G., Yurko-Mauro, K., Nelson, E.B., Van Dyck, C., et al. (2010) Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Trial. JAMA , 304, 1903-1911. https://doi.org/10.1001/jama.2010.1510
Sinn, N., Milte, C.M., Street, S.J., Buckley, J.D., Coates, A.M., Petkov, J., et al. (2011) Effects of n -3 Fatty Acids, EPA v . DHA, on Depressive Symptoms, Quality of Life, Memory and Executive Function in Older Adults with Mild Cognitive Impairment: A 6-Month Randomised Controlled Trial. British Journal of Nutrition , 107, 1682-1693. https://doi.org/10.1017/s0007114511004788
Schaefer, E.J., Bongard, V., Beiser, A.S., Lamon-Fava, S., Robins, S.J., Au, R., et al. (2006) Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease: The Framingham Heart Study. Archives of Neurology , 63, 1545-1550. https://doi.org/10.1001/archneur.63.11.1545
Benton, D., Donohoe, R.T., Clayton, D.E. and Long, S.J. (2012) Supplementation with DHA and the Psychological Functioning of Young Adults. British Journal of Nutrition , 109, 155-161. https://doi.org/10.1017/s0007114512000566
Zhang, Y., Lou, Y., Hu, J., Miao, R. and Ma, F. (2017) DHA Supplementation Improves Cognitive Function via Enhancing A β -Mediated Autophagy in Chinese Elderly with Mild Cognitive Impairment: A Randomised Placebo-Controlled Trial. Journal of Neurology , Neurosurgery & Psychiatry , 89, 382-388. https://doi.org/10.1136/jnnp-2017-316176
Lee, L.K., Shahar, S., Chin, A. and Yusoff, N.A.M. (2012) Docosahexaenoic Acid-Concentrated Fish Oil Supplementation in Subjects with Mild Cognitive Impairment (MCI): A 12-Month Randomised, Double-Blind, Placebo-Controlled Trial. Psychopharmacology , 225, 605-612. https://doi.org/10.1007/s00213-012-2848-0
Hashimoto, M., Kato, S., Tanabe, Y., Katakura, M., Mamun, A.A., Ohno, M., et al. (2016) Beneficial Effects of Dietary Docosahexaenoic Acid Intervention on Cognitive Function and Mental Health of the Oldest Elderly in Japanese Care Facilities and Nursing Homes. Geriatrics & Gerontology International , 17, 330-337. https://doi.org/10.1111/ggi.12691
Vakhapova, V., Cohen, T., Richter, Y., Herzog, Y. and Korczyn, A.D. (2010) Phosphatidylserine Containing ω -3 Fatty Acids May Improve Memory Abilities in Non-Demented Elderly with Memory Complaints: A Double-Blind Placebo-Controlled Trial. Dementia and Geriatric Cognitive Disorders , 29, 467-474. https://doi.org/10.1159/000310330
Jackson, P., Forster, J., Bell, J., Dick, J., Younger, I. and Kennedy, D. (2016) DHA Supplementation Alone or in Combination with Other Nutrients Does Not Modulate Cerebral Hemodynamics or Cognitive Function in Healthy Older Adults. Nutrients , 8, Article 86. https://doi.org/10.3390/nu8020086
Andrieu, S., Guyonnet, S., Coley, N., Cantet, C., Bonnefoy, M., Bordes, S., et al. (2017) Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Intervention on Cognitive Function in Elderly Adults with Memory Complaints (MAPT): A Randomised, Placebo-Controlled Trial. The Lancet Neurology , 16, 377-389. https://doi.org/10.1016/s1474-4422(17)30040-6
Danthiir, V., Hosking, D.E., Nettelbeck, T., Vincent, A.D., Wilson, C., O’Callaghan, N., et al. (2018) An 18-Mo Randomized, Double-Blind, Placebo-Controlled Trial of Dha-Rich Fish Oil to Prevent Age-Related Cognitive Decline in Cognitively Normal Older Adults. The American Journal of Clinical Nutrition , 107, 754-762. https://doi.org/10.1093/ajcn/nqx077
Lin, P., Cheng, C., Satyanarayanan, S.K., Chiu, L., Chien, Y., Chuu, C., et al. (2022) ω -3 Fatty Acids and Blood-Based Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment: A Randomized Placebo-Controlled Trial. Brain , Behavior , and Immunity , 99, 289-298. https://doi.org/10.1016/j.bbi.2021.10.014
Chiu, C., Su, K., Cheng, T., Liu, H., Chang, C., Dewey, M.E., et al. (2008) The Effects of ω -3 Fatty Acids Monotherapy in Alzheimer’s Disease and Mild Cognitive Impairment: A Preliminary Randomized Double-Blind Placebo-Controlled Study. Progress in Neuro - Psychopharmacology and Biological Psychiatry , 32, 1538-1544. https://doi.org/10.1016/j.pnpbp.2008.05.015
Mahmoudi, M.J., Hedayat, M., Sharifi, F., Mirarefin, M., Nazari, N., Mehrdad, N., et al. (2014) Effect of Low Dose ω -3 Poly Unsaturated Fatty Acids on Cognitive Status among Older People: A Double-Blind Randomized Placebo-Controlled Study. Journal of Diabetes & Metabolic Disorders , 13, Article No. 34. https://doi.org/10.1186/2251-6581-13-34
Bo, Y., Zhang, X., Wang, Y., You, J., Cui, H., Zhu, Y., et al. (2017) The N-3 Polyunsaturated Fatty Acids Supplementation Improved the Cognitive Function in the Chinese Elderly with Mild Cognitive Impairment: A Double-Blind Randomized Controlled Trial. Nutrients , 9, Article 54. https://doi.org/10.3390/nu9010054
Shinto, L., Quinn, J., Montine, T., Dodge, H.H., Woodward, W., Baldauf-Wagner, S., et al. (2013) A Randomized Placebo-Controlled Pilot Trial of ω -3 Fatty Acids and α Lipoic Acid in Alzheimer’s Disease. Journal of Alzheimer ’ s Disease , 38, 111-120. https://doi.org/10.3233/jad-130722
Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., et al. (2006) ω -3 Fatty Acid Treatment in 174 Patients with Mild to Moderate Alzheimer Disease: OmegAD Study: A Randomized Double-Blind Trial. Archives of Neurology , 63, 1402-1408. https://doi.org/10.1001/archneur.63.10.1402
Andriambelo, B., Stiffel, M., Roke, K. and Plourde, M. (2023) New Perspectives on Randomized Controlled Trials with ω -3 Fatty Acid Supplements and Cognition: A Scoping Review. Ageing Research Reviews , 85, Article ID: 101835. https://doi.org/10.1016/j.arr.2022.101835
Wei, B., Li, L., Dong, C., Tan, C. and Xu, W. (2023) The Relationship of ω -3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers. The American Journal of Clinical Nutrition , 117, 1096-1109. https://doi.org/10.1016/j.ajcnut.2023.04.001
Wang, L., Fan, H., He, J., Wang, L., Tian, Z. and Wang, C. (2018) Protective Effects of ω ‐3 Fatty Acids against Alzheimer’s Disease in Rat Brain Endothelial Cells. Brain and Behavior , 8, e01037. https://doi.org/10.1002/brb3.1037
Tan, Z.S., Harris, W.S., Beiser, A.S., Au, R., Himali, J.J., Debette, S., et al. (2012) Red Blood Cell ω -3 Fatty Acid Levels and Markers of Accelerated Brain Aging. Neurology , 78, 658-664. https://doi.org/10.1212/wnl.0b013e318249f6a9
Bønaa, K.H., Bjerve, K.S., Straume, B., Gram, I.T. and Thelle, D. (1990) Effect of Eicosapentaenoic and Docosahexaenoic Acids on Blood Pressure in Hypertension. A Population-Based Intervention Trial from the Tromso Study. New England Journal of Medicine , 322, 795-801. https://doi.org/10.1056/nejm199003223221202
Keli, S.O., Feskens, E.J. and Kromhout, D. (1994) Fish Consumption and Risk of Stroke. The Zutphen Study. Stroke , 25, 328-332. https://doi.org/10.1161/01.str.25.2.328
Calder, P.C. (2004) n -3 Fatty Acids and Cardiovascular Disease: Evidence Explained and Mechanisms Explored. Clinical Science , 107, 1-11. https://doi.org/10.1042/cs20040119
Kelley, D.S., Siegel, D., Vemuri, M., Chung, G.H. and Mackey, B.E. (2008) Docosahexaenoic Acid Supplementation Decreases Remnant-Like Particle-Cholesterol and Increases the (n-3) Index in Hypertriglyceridemic Men. The Journal of Nutrition , 138, 30-35. https://doi.org/10.1093/jn/138.1.30
Cole, G.M. and Frautschy, S.A. (2010) DHA May Prevent Age-Related Dementia. The Journal of Nutrition , 140, 869-874. https://doi.org/10.3945/jn.109.113910
Ouellet, M., Emond, V., Chen, C.T., Julien, C., Bourasset, F., Oddo, S., et al. (2009) Diffusion of Docosahexaenoic and Eicosapentaenoic Acids through the Blood-Brain Barrier: An in Situ Cerebral Perfusion Study. Neurochemistry International , 55, 476-482. https://doi.org/10.1016/j.neuint.2009.04.018
von Schacky, C. (2021) Importance of EPA and DHA Blood Levels in Brain Structure and Function. Nutrients , 13, Article 1074. https://doi.org/10.3390/nu13041074
Salem, N., Litman, B., Kim, H. and Gawrisch, K. (2001) Mechanisms of Action of Docosahexaenoic Acid in the Nervous System. Lipids , 36, 945-959. https://doi.org/10.1007/s11745-001-0805-6
Abu-Mweis, S., Abu Omran, D., Al-Shami, I. and Jew, S. (2021) The Ratio of Eicosapentaenoic Acid to Docosahexaenoic Acid as a Modulator for the Cardio-Metabolic Effects of ω -3 Supplements: A Meta-Regression of Randomized Clinical Trials. Complementary Therapies in Medicine , 57, Article ID: 102662. https://doi.org/10.1016/j.ctim.2021.102662
Bhatt, D.L. and Kumbhani, D.J. (2022) American College of Cardiology. Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial—RE-DUCE-IT. https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2018/11/08/22/48/REDUCE-IT
Vidgren, H.M., Ågren, J.J., Schwab, U., Rissanen, T., Hänninen, O. and Uusitupa, M.I.J. (1997) Incorporation of N-3 Fatty Acids into Plasma Lipid Fractions, and Erythrocyte Membranes and Platelets during Dietary Supplementation with Fish, Fish Oil, and Docosahexaenoic Acid-Rich Oil among Healthy Young Men. Lipids , 32, 697-705. https://doi.org/10.1007/s11745-997-0089-x
Health Canada (2024) Natural Health Product. Fish Oil. https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=fish.oil.huile.poisson&lang=eng